The Current Ratio as of March 2026 (TTM) for Precision BioSciences, Inc. (DTIL) is 13.32

According to Precision BioSciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 13.32. This represents a change of 86.50% compared to the average of 7.14 of the last 4 quarters.

Precision BioSciences, Inc. (DTIL) Historical Current Ratio (quarterly & annually)

How has DTIL Current Ratio performed in the past?

The mean historical Current Ratio of Precision BioSciences, Inc. over the last ten years is 6.64. The current 13.32 Current Ratio has changed 19.96% with respect to the historical average. Over the past ten years (40 quarters), DTIL's Current Ratio was at its highest in in the June 2019 quarter at 14.99. The Current Ratio was at its lowest in in the March 2018 quarter at 0.

Precision BioSciences, Inc. (DTIL) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Precision BioSciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Precision BioSciences, Inc. (DTIL) Average Current Ratio

How has DTIL Current Ratio performed in the past?

The current Current Ratio of Precision BioSciences, Inc. (DTIL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Precision BioSciences, Inc. (DTIL) Current Ratio vs. Peers

How is DTIL’s Current Ratio compared to its peers?

Precision BioSciences, Inc.’s Current Ratio is greater than Metagenomi, Inc. Common Stock (7.22), greater than ALX Oncology Holdings Inc. (2.07), greater than Adverum Biotechnologies, Inc. (0.65), greater than Artiva Biotherapeutics, Inc. (8.61), greater than Sutro Biopharma, Inc. (2.53), greater than Fractyl Health, Inc. Common Stock (4.27), greater than Repare Therapeutics Inc. (10.71), greater than aTyr Pharma, Inc. (5.30), greater than Connect Biopharma Holdings Limited (7.24), greater than Quince Therapeutics, Inc. (1.12),

Build a custom stock screener for Precision BioSciences, Inc. (DTIL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Precision BioSciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Precision BioSciences, Inc. (DTIL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Precision BioSciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.